{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T02:10:37Z","timestamp":1773713437783,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"publisher","award":["2023J01552"],"award-info":[{"award-number":["2023J01552"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013795","name":"Fujian Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013795","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017954","name":"Fujian Provincial Finance Department","doi-asserted-by":"publisher","award":["22SCZZX005"],"award-info":[{"award-number":["22SCZZX005"]}],"id":[{"id":"10.13039\/100017954","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.ejphar.2025.177974","type":"journal-article","created":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T16:49:43Z","timestamp":1752857383000},"page":"177974","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Everolimus alleviates cognitive dysfunction in 5\u00d7FAD mice by regulating mitochondrial function and oxidative stress"],"prefix":"10.1016","volume":"1003","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-7755-313X","authenticated-orcid":false,"given":"Fei","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"WenRong","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kualiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhou","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2025.177974_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2023.102162","article-title":"Lifestyle strategies to promote proteostasis and reduce the risk of Alzheimer's disease and other proteinopathies","volume":"93","author":"Almeida","year":"2024","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.ejphar.2025.177974_bib2","doi-asserted-by":"crossref","first-page":"675","DOI":"10.2174\/1570159X19666210517114016","article-title":"Mitochondrial dysfunction in Alzheimer's Disease: opportunities for drug development","volume":"20","author":"Bhatia","year":"2022","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.ejphar.2025.177974_bib3","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/ndt\/gfv249","article-title":"Everolimus for renal angiomyolipoma in patients with Tuberous sclerosis complex or sporadic lymphangioleiomyomatosis: extension of a randomized controlled trial","volume":"31","author":"Bissler","year":"2016","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.ejphar.2025.177974_bib4","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/509654","article-title":"Mitochondrial dysfunction contributes to the pathogenesis of Alzheimer's Disease","volume":"2015","author":"Cabezas-Opazo","year":"2015","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.ejphar.2025.177974_bib5","doi-asserted-by":"crossref","first-page":"13107","DOI":"10.1074\/jbc.M110.100420","article-title":"Molecular interplay between mammalian target of rapamycin (mTOR), amyloid-beta, and Tau: effects on cognitive impairments","volume":"285","author":"Caccamo","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2025.177974_bib6","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.expneurol.2018.09.011","article-title":"Early intrathecal infusion of everolimus restores cognitive function and mood in a murine model of Alzheimer's disease","volume":"311","author":"Cassano","year":"2019","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ejphar.2025.177974_bib7","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s12035-013-8539-y","article-title":"Intracerebroventricular streptozotocin exacerbates Alzheimer-like changes of 3xTg-AD mice","volume":"49","author":"Chen","year":"2014","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.ejphar.2025.177974_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25147952","article-title":"Targeting mitochondrial dysfunction and reactive oxygen species for neurodegenerative disease treatment","volume":"25","author":"Choi","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2025.177974_bib9","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.tibs.2016.01.001","article-title":"Mitochondrial cristae: where beauty meets functionality","volume":"41","author":"Cogliati","year":"2016","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.ejphar.2025.177974_bib10","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/s41573-020-0072-x","article-title":"Brain energy rescue: an emerging therapeutic concept for neurodegenerative disorders of ageing","volume":"19","author":"Cunnane","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejphar.2025.177974_bib11","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/nature06322","article-title":"mTOR controls mitochondrial oxidative function through a YY1-PGC-1alpha transcriptional complex","volume":"450","author":"Cunningham","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2025.177974_bib12","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.tins.2013.03.002","article-title":"Why size matters - balancing mitochondrial dynamics in Alzheimer's disease","volume":"36","author":"DuBoff","year":"2013","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.ejphar.2025.177974_bib13","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/nm1788","article-title":"Reversal of learning deficits in a Tsc2+\/- mouse model of tuberous sclerosis","volume":"14","author":"Ehninger","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejphar.2025.177974_bib14","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0140-6736(12)61134-9","article-title":"Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with Tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial","volume":"381","author":"Franz","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2025.177974_bib15","article-title":"Mitochondrial dynamics: biogenesis, fission, fusion, and mitophagy in the regulation of stem cell behaviors","volume":"2019","author":"Fu","year":"2019","journal-title":"Stem Cell. Int."},{"key":"10.1016\/j.ejphar.2025.177974_bib16","doi-asserted-by":"crossref","first-page":"5157","DOI":"10.1523\/JNEUROSCI.1820-20.2021","article-title":"Amyloid-Beta mediates homeostatic synaptic plasticity","volume":"41","author":"Galanis","year":"2021","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2025.177974_bib17","first-page":"101","article-title":"Everolimus. Recent results","volume":"211","author":"Hasskarl","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejphar.2025.177974_bib18","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222111520","article-title":"Disentangling mitochondria in Alzheimer's Disease","volume":"22","author":"Johri","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2025.177974_bib19","doi-asserted-by":"crossref","first-page":"C641","DOI":"10.1152\/ajpcell.00222.2006","article-title":"Mitochondria and neuronal activity","volume":"292","author":"Kann","year":"2007","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.ejphar.2025.177974_bib20","doi-asserted-by":"crossref","first-page":"2820","DOI":"10.1016\/j.bbamcr.2016.09.003","article-title":"A\u03b2-Induced Drp1 phosphorylation through Akt activation promotes excessive mitochondrial fission leading to neuronal apoptosis","volume":"1863","author":"Kim","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejphar.2025.177974_bib21","doi-asserted-by":"crossref","first-page":"3359","DOI":"10.1111\/bph.13626","article-title":"Continuous administration of the mTORC1 inhibitor everolimus induces tolerance and decreases autophagy in mice","volume":"173","author":"Kurdi","year":"2016","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.177974_bib22","doi-asserted-by":"crossref","first-page":"4285","DOI":"10.1016\/j.transproceed.2009.08.050","article-title":"Immunosuppression using the mammalian target of rapamycin (mTOR) inhibitor everolimus: pilot study shows significant cognitive and affective improvement","volume":"41","author":"Lang","year":"2009","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.ejphar.2025.177974_bib23","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1093\/neuonc\/nov152","article-title":"Differentiating the mTOR inhibitors everolimus and sirolimus in the treatment of Tuberous sclerosis complex","volume":"17","author":"MacKeigan","year":"2015","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.ejphar.2025.177974_bib24","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1093\/hmg\/ddr139","article-title":"Impaired mitochondrial dynamics and abnormal interaction of amyloid beta with mitochondrial protein Drp1 in neurons from patients with Alzheimer's disease: implications for neuronal damage","volume":"20","author":"Manczak","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ejphar.2025.177974_bib25","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/s43587-023-00416-y","article-title":"Targeting the biology of aging with mTOR inhibitors","volume":"3","author":"Mannick","year":"2023","journal-title":"Nat Aging"},{"key":"10.1016\/j.ejphar.2025.177974_bib26","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaq1564","article-title":"TORC1 inhibition enhances immune function and reduces infections in the elderly","volume":"10","author":"Mannick","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ejphar.2025.177974_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.617588","article-title":"Mitochondrial dysfunction and oxidative stress in Alzheimer's Disease","volume":"13","author":"Misrani","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.ejphar.2025.177974_bib28","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.molcel.2017.08.013","article-title":"mTOR controls mitochondrial dynamics and cell survival via MTFP1","volume":"67","author":"Morita","year":"2017","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ejphar.2025.177974_bib29","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1098\/rstb.2006.2018","article-title":"Neurodegeneration and cell replacement","volume":"363","author":"Ormerod","year":"2008","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"10.1016\/j.ejphar.2025.177974_bib30","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1152\/physrev.00030.2022","article-title":"Oxidative damage in neurodegeneration: roles in the pathogenesis and progression of Alzheimer disease","volume":"104","author":"Perluigi","year":"2024","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.ejphar.2025.177974_bib31","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1007\/s11357-024-01118-y","article-title":"Mitochondrial disorders leading to Alzheimer's disease-perspectives of diagnosis and treatment","volume":"46","author":"Pszczo\u0142owska","year":"2024","journal-title":"Geroscience"},{"key":"10.1016\/j.ejphar.2025.177974_bib32","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1186\/s13063-016-1446-6","article-title":"The use of everolimus in the treatment of neurocognitive problems in tuberous sclerosis (TRON): study protocol for a randomised controlled trial","volume":"17","author":"Randell","year":"2016","journal-title":"Trials"},{"key":"10.1016\/j.ejphar.2025.177974_bib33","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.exger.2014.12.002","article-title":"How longevity research can lead to therapies for Alzheimer's disease: the rapamycin story","volume":"68","author":"Richardson","year":"2015","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.ejphar.2025.177974_bib34","doi-asserted-by":"crossref","first-page":"5681","DOI":"10.1007\/s11357-024-01187-z","article-title":"Everolimus alleviates CD4(+) T cell inflammation by regulating autophagy and cellular redox homeostasis","volume":"46","author":"Rockhold","year":"2024","journal-title":"Geroscience"},{"key":"10.1016\/j.ejphar.2025.177974_bib35","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24010107","article-title":"Pathogenesis of Alzheimer's Disease","volume":"24","author":"Rostagno","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2025.177974_bib36","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s00406-016-0703-8","article-title":"mTOR inhibitor reverses autistic-like social deficit behaviours in adult rats with both Tsc2 haploinsufficiency and developmental status epilepticus","volume":"267","author":"Schneider","year":"2017","journal-title":"Eur. Arch. Psychiatr. Clin. Neurosci."},{"key":"10.1016\/j.ejphar.2025.177974_bib37","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20112774","article-title":"mTOR and aging: an old fashioned dress","volume":"20","author":"Stallone","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2025.177974_bib38","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1046\/j.1460-9568.2003.02820.x","article-title":"Rapamycin-sensitive signalling in long-term consolidation of auditory cortex-dependent memory","volume":"18","author":"Tischmeyer","year":"2003","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.ejphar.2025.177974_bib39","doi-asserted-by":"crossref","first-page":"5507","DOI":"10.2174\/138161282035140911142118","article-title":"Mitochondrial biogenesis: pharmacological approaches","volume":"20","author":"Valero","year":"2014","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ejphar.2025.177974_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2024.114889","article-title":"Mitophagy activation by rapamycin enhances mitochondrial function and cognition in 5\u00d7FAD mice","volume":"463","author":"Zheng","year":"2024","journal-title":"Behav. Brain Res."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925007289?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925007289?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T22:51:04Z","timestamp":1772751064000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299925007289"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":40,"alternative-id":["S0014299925007289"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.177974","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Everolimus alleviates cognitive dysfunction in 5\u00d7FAD mice by regulating mitochondrial function and oxidative stress","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.177974","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"177974"}}